.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

Matthias Schwab

Stuttgart / DE

Chair

26/03/2025
10:15 – 11:45
Symposien
Membrane transporters - scientific advances from in-vitro studies to clinical relevance
Hörsaal C

Further involvements

26/03/2025
15:15 – 15:30 10 Min. 5 Min.
Short talk
23
Feasibility and safety of supplementation of TAMoxifen with low-dose ENDOXifen in breast cancer patients with compromised CYP2D6-mediated tamoxifen bioactivation (TAMENDOX): a multi-center, placebo controlled, randomized trial
Applied Pharmacology, Pharmacogenomics and personalized medicine
26/03/2025
15:30 – 15:45 10 Min. 5 Min.
Short talk
24
A pharmacokinetics, pharmacodynamics, and pharmacogenomics study of the diuretic drug hydrochlorothiazide in healthy volunteers
Applied Pharmacology, Pharmacogenomics and personalized medicine
26/03/2025
Poster Self-Study
P099
Establishment of a CRISPR/Cas9-derived ABCB1/ABCG2 Knockout Platform for Enhanced Drug Transport Analysis
Basic Research, Drug transport/delivery and metabolism
26/03/2025
Poster Self-Study
P098
Refinement of the role of the drug transporters ABCC1 and ABCC2 in response to anti-tumor therapy applying a CRISPR/Cas9-derived knockout model
Basic Research, Drug transport/delivery and metabolism
27/03/2025
08:30 – 08:45 10 Min. 5 Min.
Short talk
56
PharmFreq: a comprehensive database of worldwide allelic frequencies in clinically important pharmacogenes
Applied Pharmacology, Pharmacogenomics and personalized medicine
27/03/2025
09:00 – 09:15 10 Min. 5 Min.
Short talk
41
Is pharmacogenetic testing relevant for paediatric inpatient prescribing of drugs – a German perspective
Applied Pharmacology, Pharmacoepidemiology and drug safety
27/03/2025
Poster Self-Study
P209
The contribution of NFI transcription factors to the variable hepatic Cytochrome P450 expression
Applied Pharmacology, Pharmacogenomics and personalized medicine
27/03/2025
Poster Self-Study
P211
Interactions of the breast cancer drug tamoxifen with the gut microbiome: from clinical associations to functional investigations
Applied Pharmacology, Pharmacogenomics and personalized medicine
27/03/2025
Poster Self-Study
P210
An LC-MS/MS Assay for Therapeutic Drug Monitoring of 10 Drug Compounds Commonly Used in Antimicrobial Therapy for Critically Ill Patients
Applied Pharmacology, Pharmacogenomics and personalized medicine
27/03/2025
Poster Self-Study
P163
TAM metabolites induce altered K⁺ and Ca²⁺ dynamics in human and mouse breast cancer cells through BK_Ca activation
Basic Research, Ion channels and membrane transporters